RNLS:FAD oxidises dh-beta-NAD to NAD+

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Renalase (RNLS) is a flavoprotein that is secreted by the kidney and circulates in blood from where it can regulate blood pressure, regulate sodium and phosphate excretion and display cardioprotectivity through a mechanism which is not understood to date. RNLS, using FAD as cofactor, can oxidise isomeric forms of beta-NAD(P)H that can arise either by nonspecific reduction of beta-NAD(P)+ or by tautomerisation of beta-NAD(P)H (Milani et al. 2011, Beaupre et al. 2015). These forms are 1,2- and 1,6-dihydroNAD(P) (dh-beta-NAD(P)) and are potent inhibitors of primary metabolism dehydrogenases. RNLS may thus play a role in eliminating these isomeric forms which threaten normal respiratory activity.

Literature References
PubMed ID Title Journal Year
25531177 Metabolic function for human renalase: oxidation of isomeric forms of ╬▓-NAD(P)H that are inhibitory to primary metabolism

Moran, GR, Roman, J, F├Ârsterling, FH, Hoag, MR, Beaupre, BA

Biochemistry 2015
21699903 FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation

Aliverti, A, Bolognesi, M, Baroni, S, Canevari, G, Ciriello, F, Milani, M, Pandini, V

J. Mol. Biol. 2011
Catalyst Activity

oxidoreductase activity, acting on NAD(P)H of RNLS:FAD [extracellular region]

Orthologous Events
Cite Us!